Protalix BioTherapeutics Inc (PLX)
1.165
-0.04
(-3.72%)
USD |
NYAM |
May 02, 16:00
1.165
0.00 (0.00%)
After-Hours: 19:20
Protalix BioTherapeutics Free Cash Flow: -2.467M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.467M |
| September 30, 2023 | -8.636M |
| June 30, 2023 | -10.56M |
| March 31, 2023 | -22.82M |
| December 31, 2022 | -25.63M |
| September 30, 2022 | -28.34M |
| June 30, 2022 | -21.30M |
| March 31, 2022 | -7.582M |
| December 31, 2021 | -11.74M |
| September 30, 2021 | -14.03M |
| June 30, 2021 | -15.52M |
| March 31, 2021 | -29.80M |
| December 31, 2020 | -26.76M |
| September 30, 2020 | -22.65M |
| June 30, 2020 | -22.56M |
| March 31, 2020 | -19.72M |
| December 31, 2019 | -19.98M |
| September 30, 2019 | -20.46M |
| June 30, 2019 | -3.31M |
| March 31, 2019 | -6.212M |
| December 31, 2018 | -8.428M |
| September 30, 2018 | 13.06M |
| June 30, 2018 | -11.15M |
| March 31, 2018 | -11.98M |
| December 31, 2017 | -10.96M |
| Date | Value |
|---|---|
| September 30, 2017 | -35.72M |
| June 30, 2017 | -28.64M |
| March 31, 2017 | -31.72M |
| December 31, 2016 | -32.95M |
| September 30, 2016 | -29.35M |
| June 30, 2016 | -34.54M |
| March 31, 2016 | -28.10M |
| December 31, 2015 | -24.75M |
| September 30, 2015 | -25.93M |
| June 30, 2015 | -26.94M |
| March 31, 2015 | -27.98M |
| December 31, 2014 | -30.07M |
| September 30, 2014 | -29.99M |
| June 30, 2014 | -28.74M |
| March 31, 2014 | -30.92M |
| December 31, 2013 | -32.54M |
| September 30, 2013 | -26.01M |
| June 30, 2013 | -26.26M |
| March 31, 2013 | -4.57M |
| December 31, 2012 | -1.433M |
| September 30, 2012 | -10.32M |
| June 30, 2012 | -10.65M |
| March 31, 2012 | -29.77M |
| December 31, 2011 | -29.28M |
| September 30, 2011 | -31.03M |
Free Cash Flow Range, Past 5 Years
-29.80M
Minimum
Mar 2021
-2.467M
Maximum
Dec 2023
-17.57M
Average
-19.98M
Median
Dec 2019
Free Cash Flow Benchmarks
| Agenus Inc | -234.16M |
| InfuSystems Holdings Inc | 0.106M |
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.595M |
| Cash from Investing (Quarterly) | -0.342M |
| Free Cash Flow Per Share (Quarterly) | 0.0386 |
| Free Cash Flow to Equity (Quarterly) | 3.286M |
| Free Cash Flow to Firm (Quarterly) | 4.108M |
| Free Cash Flow Yield | -2.72% |